Page 73 - Clinical Olfactory Working Group Consensus Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical olfactory working group consensus statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Olfactory Working Group Consensus Statement Today - Breaking & Trending Today

Welcome To IANS Live - BUSINESS - Samsung, Sony, Hitachi invest in UK healthtech firm Huma

Photo Credit: IANS
IANSLive
London, May 12 (IANS) Samsung, Sony and Hitachi have invested in UK heathtech company Huma Therapeutics Limited in its latest Series C funding round with financing of approximately $130 million, the company said on Wednesday.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 12-May-2021 ....

United Kingdom , City Of , Huma Therapeutics , News Service , India Private , Huma Therapeutics Limited , All Rights , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , ஹுமா சிகிச்சை , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

Initiated clinical trial with novel nasal spray codenamed APR-AOS2020 [...]

12 maggio 2021 16:52
Fonte: Adnkronos
#salute-e-benessere
Product recently cleared in EU as Class III medical device
BALERNA, Switzerland, May 12, 2021 /PRNewswire/ APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III medical device, in the treatment of COVID-19 patients showing mild symptoms. The study is being conducted by the Hygiene Unit of IRCCS Policlinico San Martino Hospital in Genoa, Italy and coordinated by Prof. Giancarlo Icardi as lead investigator. The study is planned to enroll a total of 57 COVID-19 patients who show mild symptoms of the disease and is evaluating the efficacy and safety of the spray product in reducing viral load in the upper respiratory airways in recently infected individuals. Resul ....

United States , Switzerland General , Paolo Galfetti , Professorgiancarlo Icardi , Giancarlo Icardi , Pharma Research , Hygiene Unit , San Martino Hospital , Antiviral Research , Utah State University , Apr Aos2020 , ஒன்றுபட்டது மாநிலங்களில் , சுவிட்சர்லாந்து ஜநரல் , பார்மா ஆராய்ச்சி , சுகாதாரம் அலகு , சான் மார்டினோ மருத்துவமனை , உட்டா நிலை பல்கலைக்கழகம் ,

Welcome To IANS Live - SCIENCE - Ibuprofen safe, doesn't raise Covid death risk: Study

NSAIDs are common treatments for acute pain and rheumatological diseases such as rheumatoid arthritis and osteoarthrosis.Earl ....

United Kingdom , City Of , News Service , India Private , All Rights , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் , சர்வதேச பரவல் ,

Welcome To IANS Live - SCIENCE AND TECHNOLOGY - Ibuprofen safe, doesn't raise Covid death risk: Study

NSAIDs are common treatments for acute pain and rheumatological diseases such as rheumatoid arthritis and osteoarthrosis.Earl ....

United Kingdom , City Of , News Service , India Private , All Rights , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் , சர்வதேச பரவல் ,

Cancer Trials Ireland: New Cancer Treatments

Clinical trial, courtesy of Pixabay
Geneva Pattison
Cancer Trials Ireland are looking for participants to take part in their virtual Cancer Retreat day on May 21st. The event, which is aimed at the cancer research community, also falls on the same day as international Clinical Trials Day.
The retreat is an open day for people in the cancer community, created to keep people informed and up to date on the cancer research and trials taking part in Ireland at the moment. This first session will be open to cancer patients, advocates and people in the community.
As mentioned by Don Delaney, director of Cancer Trials Ireland, they hope to “shed some light” on how cancer trials exactly work and how people can take part should they want to. This call out initiative is part of their “Just Ask” campaign, where CTI encourage people with a cancer diagnosis to ask their oncologist would they be suitable to take part in a clinical trial, to try help fight their disease. ....

Don Delaney , Geneva Pattison , Trials Ireland , Cancer Retreat , Clinical Trials , Cancer Trials Ireland , தாதா டெலானி , ஜிநீவ பட்டிசன் , சோதனைகள் ஐயர்ல்யாஂட் , மருத்துவ சோதனைகள் , புற்றுநோய் சோதனைகள் ஐயர்ல்யாஂட் ,